Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20048659 | 0.97 | MAOA (0.43) | AKR1C3MAOAMAOBALDH1A1MAPK1 | |
| SCHEMBL10526450 | 0.83 | IDO1 (0.55) | AKR1C3MAOBALDH1A1TDP1L3MBTL1 | |
| SCHEMBL26443961 | 0.81 | KMT2A (0.37) | ALDH1A1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL13329305 | 0.79 | AKR1C3 (0.43) | AKR1C3ALDH1A1MAPK1TDP1ATM | |
| SCHEMBL1666343 | 0.79 | KDM4E (0.55) | AKR1C3MAOAMAOBALDH1A1MAPK1 | |
| SCHEMBL26443968 | 0.78 | KMT2A (0.35) | ALDH1A1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL26443980 | 0.78 | KDM4E (0.46) | MAOAMAOBALDH1A1TDP1MEN1 | |
| SCHEMBL1004343 | 0.77 | AKR1C3 (0.57) | AKR1C3ALDH1A1MAPK1TDP1ATM | |
| SCHEMBL7821719 | 0.77 | KDM4E (0.63) | AKR1C3MAOAMAOBALDH1A1TDP1 | |
| SCHEMBL22302602 | 0.76 | ERN1 (0.49) | AKR1C3ALDH1A1MAPK1TDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230139797-A1 | FLUORESCENT DETECTION OF AMINES AND HYDRAZINES AND ASSAYING METHODS THEREOF | ILLUMINA, INC. | 2023-05-04 | — | — | US | disclosed |
| US-11530352-B2 | Fluorescent detection of amines and hydrazines and assaying methods thereof | ILLUMINA, INC. (US) | 2022-12-20 | — | — | US | disclosed |
| US-20190225880-A1 | FLUORESCENT DETECTION OF AMINES AND HYDRAZINES AND ASSAYING METHODS THEREOF | ILLUMINA, INC. (US) | 2019-07-25 | — | — | US | disclosed |
| WO-2018067472-A1 | FLUORESCENT DETECTION OF AMINES AND HYDRAZINES AND ASSAYING METHODS THEREOF | ILLUMINA, INC. (US) | 2018-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190225880-A1 | FLUORESCENT DETECTION OF AMINES AND HYDRAZINES AND ASSAYING METHODS THEREOF | NAT1, ALDH7A1, PAH | AKR1C3 835/4885MAOA 63/4885MAOB 52/4885 |
| US-20230139797-A1 | FLUORESCENT DETECTION OF AMINES AND HYDRAZINES AND ASSAYING METHODS THEREOF | NAT1, ALDH7A1, PAH | AKR1C3 835/4885MAOA 63/4885MAOB 52/4885 |
| US-11530352-B2 | Fluorescent detection of amines and hydrazines and assaying methods thereof | NAT1, ALDH7A1, PAH | AKR1C3 835/4885MAOA 63/4885MAOB 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.